查询词典 patent

Factors that could affect results include the ability to market and sell products; changes in relationships with strategic partners and reliance on strategic partners for the performance of critical activities under collaborative arrangements; failure of distributors or other customers to meet purchase forecasts or minimum purchase requirements for our products; impact of competitors, competing products and technology changes; ability to develop, commercialize and market new products; market acceptance of oral fluid testing or other new products or technology; changes in market acceptance based on product performance; continued bulk purchases by customers, including governmental agencies, and the ability to fully deploy those purchases in a timely manner; ability to fund research and development and other products and operations; ability to obtain and maintain new or existing product distribution channels; reliance on sole supply sources for critical product components; availability of related products produced by third parties; ability to obtain, and timing and cost of obtaining, necessary regulatory approval for new products or new indications or applications for existing products; ability to comply with applicable regulatory requirements; history of losses and ability to achieve sustained profitability; volatility of our stock price; uncertainty relating to patent protection and potential patent infringement claims; uncertainty and costs of litigation relating to patents and other intellectual property; availability of licenses to patents or other technology; ability to enter into international manufacturing agreements; obstacles to international marketing and manufacturing of products; ability to sell products internationally; loss or impairment of sources of capital; ability to meet financial covenants in agreements with financial institutions; ability to retain qualified personnel; exposure to product liability, patent infringement, and other types of litigation; changes in international, federal or state laws and regulations; customer consolidations and inventory practices; equipment failures and ability to obtain needed raw materials and components; the impact of terrorist attacks and civil unrest; ability to complete consolidation or restructuring activities; ability to identify, complete and realize the full benefits of potential acquisitions; and general political, business and economic conditions.

可能影响结果的因素包括营销以及出售产品的能力；与战略合作伙伴关系的变化以及根据合作协议对战略合作伙伴执行关键活动的依赖；经销商或者其他顾客未达到我方产品的采购预测或者最低采购要求；竞争对手、竞争产品以及技术变化的影响；新产品开发、商业化以及营销的能力；市场对唾液检测、其他新产品或者技术的接收程度、基于产品效果所造成的市场接收的变化；顾客、包括政府机构的持续大宗采购以及按时完成采购的能力；资助研究、开发以及其他产品和活动的能力；获得并维持新的或者现有的产品经销渠道的能力；关键产品部件对单一供应源的依赖；第三方生产的相关产品的供应情况；新产品或者现有产品的新疗效获得必要的管制批准的能力、时间以及费用；遵守适用的管制要求的能力；亏损的历史以及实现可持续盈利的能力；股票价格的波动；与专利保护和潜在的专利侵权诉讼有关的不确定性；与专利以及其他知识产权有关的不确定性以及诉讼费用；专利以及其他技术授权的提供情况；签订国际性制造协议的能力；产品进行国际营销以及制造的障碍；国际性销售产品的能力；资本来源的损失或者减少；履行与财务机构之间协议的能力；获得合格人员的能力；产品责任、专利侵权以及其他诉讼的风险；国际、联邦或者州的法律、法规的变化；顾客合并以及存货实践；设备故障以及获得所需原材料和部件的能力；恐怖主义袭击以及内乱的影响；完成合并或者重组活动的能力；识别、完成以及实现潜在收购的全部利益的能力；一般性政治、商业、经济形势等。

It especially points out the global patent distribution of special enterprises and patent situation of foreign enterprises in special field that has circled patent land in China.

为了更加明了地看到这种差距，我们从国内与外国的专利申请，尤其是在中国专利局的申请中看到这些详细的数据。

The following types of licensing practices have been found to be contrary to US antitrust law: Requiring a licensee to purchase separate unpatented products as a condition of obtaining the license for a patented product; Requiring mandatory package licensing; Forming a cartel through exclusive cross-licensing; Using a patent, trademark or trade secret as the basis for an agreement that restrains where, how or to whom a patented product is disposed of in the US after the licenser or licensee has sold the product to an independent purchaser; Agreeing in relation to a license that no further licenses will be granted to a third party without the licensee's consent; Requiring a licensee to adhere to any specified or minimum price for the licensee's sale of the licensed products; Insisting as a condition of the license that the licensee pay royalties in an amount not reasonably related to the licensee's sale of products covered by the licensed rights; Attempting to enforce a patent license or collect a royalty beyond the term of the patent (the same reasoning could apply to attempts to enforce or collect royalties on a license based on know-how that has entered the public domain); and Requiring a licensee to agree in advance to grant back to the licenser title or an exclusive license on any new patents or trade secrets related to the licensed technology rights that the licensee may obtain or develop.

下列许可行为被认为违反了美国反垄断法：●要求被许可方购买另外非专利产品作为获得某一专利产品许可的条件；以强制性一揽子方式提供许可；通过独占交叉许可组建一个企业联盟；利用一项专利，商标或商业秘密作为协议的基础，在许可方或被许可方将某一专利产品卖给一位独立买家后，限制该产品在美国的处理地点，方式和交易对象；规定某一许可在未获被许可方同意的情况下，不再向任何第三方发放许可；要求被许可方在销售其获得许可的产品时遵守特定的或最低价格；对于销售受许可权利保护的产品，要求被许可方支付不合理的特许权使用费，并以此作为获得许可的条件；试图超出专利范围强加一项专利许可或对其收取特许权使用费(同一理由可适用于试图根据已进入公共领域的技术秘密强加一项专利许可或对其收取特许权使用费)；以及对于被许可方可能获得或拥有的与被许可技术权利相关的任何新专利或商业秘密，要求被许可方事先同意向许可方回授有关权利或专属许可。

Whilst judging the aforementioned lawsuit, Microsoft Corporation sued the Patent Re-examination Board of the State Intellectual Property Office of the People's Republic of China as well as the inventors of the product in Beijing No.1 Intermediate Court on the grounds that the Zhengma method patent was null and void citing that it failed to achieve the conditions of novelty and creativity required for a patent to be granted.

此案审理期间，微软公司将中国国家知识产权局专利复审委员会和郑码的发明人起诉到北京市一中院，要求法院确认"郑码"专利无效，其理由是郑码"不具有新颖性"、"不具有创造性"。

Rule 72 After the expiration of three years from the date of the grant of the patent right, any entity may, in accordance with the provisions of Article 48 of the Patent Law, request the Patent Administration Department under the State Council to grant a compulsory license.

第七十二条自专利权被授予之日起满3年后，任何单位均可以依照专利法第四十八条的规定，请求国务院专利行政部门给予强制许可。

The principle of superfluity establishing ; The judgment of patent infringement ; The formation of the patent claim ; Patent claim interpretation

吉林大学；刘琦多余指定原则；专利侵权判定；权利要求的形成；权利要求的解释

The latter three strategies are new and also the paper's three innovative points. First of all, appeal the law to prohibit reversed payment, unify this with the BOLAR exception, and promote the drugs into the market as soon as possible. Secondly, put the public health, medicine patent and the IPRs protection of traditional knowledge and the genetic resources together. Through giving the traditional knowledge and the genetic resources IPRs protection to treat the developed countries' medicine patents, they can settle the public health crisis. Finally, the legal mechanism of Prior Consent is a new strategy that Brazil proposed for the purpose of protecting the public health, which divides the examination of patent applications for pharmaceutical products and processes between two federal agencies, National Institute of Intellectual Property and National Sanitary Supervision Agency. ANVISA has the obligation to render the final decision, granting or denying a patent.

其中前四种措施是国际社会上一直以来倡导的主要措施，后三种是新的解决公共健康危机的法律措施，其创新点在于：第一，呼吁将禁止反向支付纳入法律，并与BOLAR例外相结合使用，促进仿制药品的尽快上市；第二，将公共健康、医药品专利以及传统知识和遗传资源的知识产权保护三者紧密相连，通过对传统知识和遗传资源予以知识产权保护来应对发达国家的医药品专利；第三，&事先同意&法律制度是巴西提出的一种旨在保护公共健康，应对医药专利的新的法律制度，该制度规定凡是涉及医药品专利的申请都必须经过国家知识产权局和国家公共卫生监督局的公共审查，并且国家公共卫生监督局有是否授予专利的最终决定权。

All the records and annuals of CIPO are all available free on the website. And also Canadian Patent Database is provided, lets user access over 75 years of patent descriptions and images. User can search, retrieve and study more than 1,500,000 patent documents.

网站还提供了CIPO纪录和年报全文，并配有加拿大专利数据库供用户使用，用户可通过该数据库查询到加拿大75年来包括专利描述和图像文件在内的150多万条专利文件。

Article 80 The administrative department for patent under the State Council shall provide professional guidance to the department for the administration of patent work for disposing and conciliating patent disputes.

第八十条国务院专利行政部门应当对管理专利工作的部门处理和调解专利纠纷进行业务指导。

The patent protection scope and the damages of patent infringements are also discussed. In addition, the extinctive prescriptions of claim of damages for patent infringement, especially in the case of consecutive infringements, are discussed.

特别就积体电路电路设计专利侵权救济时效之问题，尤其是对连续侵权救济时效之部份，作一番探讨。

I use an example quoted by Hu Jiaqi:"It is reported that America separates the DNA of a kind of virus by making use of genetic technology and combines it with another kind of DNA. Finally, they get a kind of virulent biological agent called a "pyrotoxin". Someone discloses in private that 20 grams of such a kind of biological agent could result in the global death of 6 billion people due to infection."

我在这里例举胡家奇所引用过的例子："据报道，美国利用转基因技术，将一种病毒的DNA分离出来，与另外一种DNA进行结合，拼结成一种剧毒的"热毒素"生物战剂，且私下有人透露，这种生物战剂只需20克，就可以导致全球60亿人全部感染死亡。"

Waiting, for the queers and the coons and the Reds and the Jews.

等待着疯子和黑人还有红色共产主义者还有犹太人